Cytokine receptor activation at the cell surface

[Display omitted] ► Structure of the GM-CSF receptor complex reveals a dodecameric signaling unit. ► N-glycosylation of IL-7 receptor found critical for high affinity binding of IL-7. ► Structure of an IL-17R complex reveals a novel mode of cytokine recognition. ► Type 1 interferon receptors recogni...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Current opinion in structural biology 2012-06, Vol.22 (3), p.350-359
Hauptverfasser: Broughton, Sophie E, Hercus, Timothy R, Lopez, Angel F, Parker, Michael W
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:[Display omitted] ► Structure of the GM-CSF receptor complex reveals a dodecameric signaling unit. ► N-glycosylation of IL-7 receptor found critical for high affinity binding of IL-7. ► Structure of an IL-17R complex reveals a novel mode of cytokine recognition. ► Type 1 interferon receptors recognize diverse cytokines through ‘anchor points’. ► Visualization of intact gp130/IL-6/IL-6Rα ternary receptor bound to a Janus kinase. Cytokines are well recognized for the pleiotropic nature of their signaling and biological activities on many cell types and their role in health and disease. Recent years have seen a steady stream of new cytokine receptor crystal structures including those that are activated by GM-CSF, type I interferon, and a variety of interleukins. Highlights include the observation of a dodecameric signaling complex for the GM-CSF receptor, electron microscopy imaging of an intact gp130/IL-6/IL-6Rα ternary receptor complex bound to its signal transducing Janus kinase and visualization of novel cytokine recognition mechanisms in the interleukin-17 and type I interferon families. This increasing knowledge in cytokine structural biology is driving new opportunities for developing novel therapies to modulate cytokine function in a diverse range of diseases including malignancies and chronic inflammation.
ISSN:0959-440X
1879-033X
DOI:10.1016/j.sbi.2012.03.015